AnPac Bio-Medical Science Co Ltd - ADR

NASDAQ:ANPC  
4.43
-0.03 (-0.67%)
Products, Regulatory

Anpac Bio Launches Novel Cancer Treatment Technology And Product Joint Venture

Published: 05/25/2021 11:24 GMT
AnPac Bio-Medical Science Co Ltd - ADR (ANPC) - Anpac Bio Launches Novel Cancer Treatment Technology and Product Joint Venture - Utilizing Findings From 10 Years of Early-stage Cancer Detection Work Involving Over 222,200 Sample Database.
Anpac Bio-medical Science Co Ltd - Laboratory Tests on Novel Cancer Treatment Technology Expected to Begin in Q3.
Anpac Bio-medical Science Co Ltd - Class Iii Medical Device Registration Application to Chinese Nmpa Planned for Q3 2022.